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Introduction
Leiomyosarcoma of the oesophagus is a rare tumour [1]
and was first described in 1902 by Howard [2]. Almost
a century later, only 165 cases have been reported in the
literature [3]. This tumour represents less than 0.5% of all
primary gastrointestinal sarcomas and only some 5% of all
oesophageal tumours [4, 5]. Experience of this tumour,
both diagnosis and treatment, is therefore extremely
limited. 
Growth pattern and incidence
Leiomyosarcoma is a tumour which originates from the
mesenchymal smooth muscle cells. It grows submucously
and in most cases is located inside the layers of the middle
and lower parts of the oesophagus [3-5]. Its incidence is
45% for the lower-third of the oesophagus, 30% for the
middle-third, and 25% for the upper-third [3, 5-7]. There
is a distinction between the polyp and infiltrating types
of this malignancy [3]. For both sexes, leiomyosarcoma of
the oesophagus has its highest incidence in the age group
50-79 years [1, 3]. However, leiomyosarcoma is diagnosed
1.6 times more often in men than in women [3].
Symptoms
The main symptoms of this malignancy are dysphagia
(85%), loss of weight (58%) and pain (39%). More than
one-third (35%) of the reported cases experience both
dysphagia and loss of weight. Additional symptoms
include reflux oesophagitis (17%), nausea combined
with vomiting (7%) and acute bleedings (6%) [3, 8].
Leiomyosarcoma is almost never asymptomatic [3].
However, a definite diagnosis can often only be made
a year after the appearance of the first symptoms [1, 3].
Diagnostic findings
A 69 year-old male patient complained about suffering for
five months from dysphagia and relapsing post-prandial
vomiting as well as experiencing a loss of weight of 13 kg
during this period of time. Perianal bloody stool or
melanemia were denied by the patient as nicotine
addition and alcohol abuse. The family history did not
show any malignant diseases. 
Because of the dysphagia we performed a gastro-
scopy and this showed a semicircular, stenosing, exophytic
growth which was suspicious of a malignancy. This was
sited 25–32 cm from the superior aspect of the
oesophagus, Figure 1. In-patient hospital admission took
place for purposes of histological clarification and to
obtain a definitive diagnosis. 
On clinical examination, the patient’s height was
1.83 m and weight 80 kg and he was assessed to be in
good general and nutritional condition. The examination
found no clinical abnormalities and no indications of
a disease pathology. The common laboratory findings
were all within normal ranges. The tumour markers
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(CEA, Ca 19-9, Ca 50, Ca 72-4, PSA) except for a slightly
higher NSE (29 ng/ml, normal range 12 ng/ml) were also
all in their normal ranges. 
During diagnostic investigative procedures including
ECG, bronchoscopy and total body bone scanning, as
well as sonography and computed tomography of the
abdomen no abnormal pathological findings were
observed. X-rays of the thorax in two planes and pulmo-
nary function studies indicated in the images, the start
of bronchial asthma with reversible obstruction. A barium
study of the gastrointestinal tract, Figure 2, using water
soluble contrast medium showed a 4-5 cm long stenosis of
the middle-third of the oesophagus, with obviously
delayed contrast medium outflow. 
In terms of diagnosis, a fistula could be excluded.
The computed tomography (CT) imaging results showed
a 3 cm x 4 cm space occupying mass at the height of the
aortic arch with pre-stenotic dilatation of the oesophagus.
In addition there were several small lymph nodes with
a diameter of less than 1 cm but without any evidence of
metastatically suspicious spherical lesions in the lungs. 
To complete the pre-operative staging for this
patient, an endosonoscopy was performed, Figure 3. This
confirmed the earlier CT findings with a 2.5 cm x 3.7 cm
echo-poor, inhomogeneous, semicircular stenosing
tumour at 25-32 cm from the superior aspect of the
oesophagus. Also indicated was penetration of the
adventitia. 
The images also suggested that the tumour abutted
the thoracic aorta with the possibility of infiltration. It
was possible to display up to 1 cm sized peri-tumoural
lymph nodes. The histological analysis of the tissue
samples were indicative of a spindle cell shaped sarcoma.
After additional immunohistochemical testing (KI1,
keratin 8, S100, actin, desmin) and a positive actin
reaction, we suspected the existence of a leiomyosarcoma
of the oesophagus of stage T4, N1, M0, G2.
Treatment strategy
After pre-operative preparation, including additive
parenteral hyperalimentation, we performed a thoraco-
abdomino-cervical en bloc resection of the oesophagus
with a stomach tube as an oesophageal replacement. On
the fourth post-operative day our patient developed
clinical indications of an anastomosis insufficiency. We
immediately performed a surgical revision. The cause of
the complication was found to be stomach tube necrosis
with incipient mediastinitis. After re-thoracotomy on the
right side of the chest, we resected the stomach tube,
occluded the remaining stomach stump and drained both
pleural cavities and the mediastinum. 
The disconnection of the stomach tube made
necessary the implantation of a small intestine nutritional
catheter. Subsequently, during the same surgical session,
we performed a cervical resection of the remaining
stomach tube as well as a hemi-thyroidectomy on the left
side. This was due to a lack of space required in order to
install a terminal salivary fistula. The further post-
operative course was without pathological findings. 
17
Figure 1. Endoscopic pre-treatment imaging
Figure 2. Pre-operative barium contrast imaging
Figure 3. Endosonographic imaging for assessment of tumour staging
After eight weeks of anastasis, a temporary discharge
was observed and the patient was re-admitted. We then
performed an isoperistaltical colon interposition in order
to reestablish the recontstructed oesophageal passage.
Due to the vascular architecture, Figure 4, which was
detected using angiography. Because of adequate
mobility, the right hemicolon including the terminal ileum
were chosen as interposition material after an
appendectomy. It was demonstrated, intraoperatively,
that the arterial blood supply was sufficient via the arteria
colica media as well as its venous outflow. 
Because of the expected late stage of the tumour,
T4, and a planned post-operative irradiation, we decided
to dislocate the colon interposition through a retrosternal
path to the cervical level. The post-operative development
was satisfactorily accomplished and an assessment of the
anastomosis using water soluble contrast medium
appeared to be sufficient. A gradual alimentation build-up
was initiated on the fifth post-operative day and after
three weeks the patient was discharged. Adjuvant
radiotherapy of 50.4 Gy was given without any need for
the patient to be hospitalised. 
Post-operative histological findings on the surgical
specimen showed a 7 cm diameter moderately differen-
tiated leiomyosarcoma of the oesophagus with infiltration
of the muscularis propria as well as of the adventitia, but
without any evidence of affected lymph nodes, T2 N0
M0, G2, R0.
Follow-up
Currently, the patient is in very good general and
nutritional condition. Since his discharge from in-patient
treatment he has gained 7 kg in weight after initial
additive parenteral hyperalimentation. He is now able to
ingest nutrition of any kind, not dependent on its
consistency. He has no post-treatment complaints.
Discussion and conclusions
Leiomyosarcoma of the oesophagus is a rare tumour and
the space occupying mass does not necessarily cause
immediate symptoms. It is essential to be able to diffe-
rentiate between a benign leiomyoma and a malignant
leiomyosarcoma in order to determine the therapeutic
strategy. Histologically this is often quite complicated [1,
3, 5, 8]. The leiomyosarcoma consists of spindle-cell-like
cells with long drawn-out nuclei and eosinophilic cyto-
plasm. The distinction between the malignant leiomyo-
sarcoma and benign leiomyoma depends on the amount
of mitosis, the cell concentration and the evidence of
cellular atypia with or without necroses, in order to
determine the grade of malignancy [5, 9] of which there
are four, Table I [5].
A differentiation between the benign leiomyoma
and malignant leiomyosarcoma solely through immuno-
histochemical studies does not work [3]. The detection
of vimentin and actin characterises the mesenchymal
smooth muscle cells and allows a distinction from tumours
which arise from epithelial cells and show a positive
reaction to cytokeratin, such as for example, spindle cell
carcinomas [3]. A diagnosis of oesophageal carcinoma
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Figure 4. Angiographic imaging of the mesenteric vessels
Table I. Histological grading of leiomyosarcoma, after Pesarini et al [5]
Only a small increase in the number of mitoses when compared to leiomyomas
Grade 1. Only slightly higher concentration of cells as in leiomyomas
No cellular pleomorphism
An increase in the number of mitoses: at least in 1 of 5 high power fields
Grade 2. A moderately higher concentration of cells as in leiomyomas
A greater nucleocytoplasmatic ratio than leiomyomas
A higher rate of mitoses: more than 1 in 5 high power fields
Grade 3. An obviously higher concentration of cells as in leiomyomas
Cellular pleomorphism
Numerous mitoses
Grade 4 A very high concentration of cells
Cellular pleomorphism with atypia of the nucleus
always needs to be ruled out before leiomyosarcoma can
be diagnosed [1, 3].
Leiomyosarcomas can often grow intralumenally and
as polyps but rarely intramurally and invasively [3]. If an
invasively growing leiomyosarcoma leaves an intact
mucous membrane of the oesophagus and if the tumour is
not clearly recognisable, it is possible that a superficial
tissue sample can falsely lead to a negative histology [10].
Clinical parameters which are required in order to
fully estimate malignancy, include size increase over
a period of time, infiltration grade, the presence of
a displacing growth which cause the patient to complain
[1, 3]. The major symptoms of leiomyosarcoma of the
oesophagus are dysphagia and loss of weight, but they
are not specific only to this disease [1].
The use of diagnostic endosonography is very
important. This is because a leiomyosarcoma presents as
echo-poor and usually inhomogeneous, arising from the
lamina muscularis mucosae or lamina muscularis propria
[12]. Sometimes, intratumoural necroses or calcifications
are visible, and therefore it is not possible to distinguish
the tumour from its surroundings [3, 5]. Pre-operative
diagnostic imaging often indicates suspected tumour
infiltration of the aorta or of other arterial blood vessels.
However, intraoperative findings show in most cases that
arterial vascular structures are normal and are not
infiltrated by the neoplasm.
The pre-operative studies which are necessary
include chest X-rays, abdominal sonography, gastroscopy
with tissue sample biopsy, endosonography, barium
radiographic studies of the oesophagus employing water
soluble contrast medium and CT of the abdomen. These
should be considered to be standard procedures in order
to obtain an accurate diagnosis and to eliminate the
possibility of distant metastases [3, 5]. Total body bone
scanning and bronchoscopy are not considered by us to be
essential.
A literature review reveals that at the time of the
diagnosis already one-third of leiomyosarcomas have
developed distant metastases [3, 10]. The most frequently
affected organs are liver and lung, because of haema-
togenic dissemination. In rare cases a lymphogenic
metastasis is possible [1, 3-5, 8].
Resection of the oesophagus with stomach tube
replacement is the first choice treatment strategy [1, 3-5,
8, 11]. In spite of the surgical risk involved, which is not
negligible, approximately 70% of the tumors can be
curatively resected [5, 6] and a five-year survival rate can
be achieved in the range 20–40 % [1, 3, 5, 12]. The most
important prognostic factors are the grade of malignancy
and tumour growth rate [1, 5, 12]. The existence of
metastases is not a contraindication for surgery, because
even in these cases a significantly improved survival can
be achieved. Even though this is a palliative tumour
resection or selective extirpation of metastases [11, 13].
The most severe complication after an oesophageal
replacement procedure interposition-necrosis and is
reported to be some 2% of all cases. The most reliable
verification of a successful surgical procedure can be
achieved by an early endoscopic examination of the
interposition [20]. If post-operatively a patient develops
a stomach tube necrosis, it is essential that a strict
complication management is followed. This includes early
revision with stomach tube resection, blind plugging of the
stomach stump, generous thorax and mediastinum
drainage, installation of a terminal salivary fistula and of
a small intestine nutritional catheter. In addition there
must be adequate convalescence in order to be able to
accomplish later the recreation of the passage continuity
among infection-free tissue [20]. 
After an extensive search of the literature we have
come to the conclusion that internationally there is only
very limited experience of the surgical procedure of colon
interposition. For example, in 2002 in Germany only 22
centres reported any experience with this disease [15]. 
If a stomach tube as an oesophageal replacement is
not possible, for example after gastrectomy, or after
a two-thirds resection of the stomach or a stomach tube
necrosis, it is still possible to either use the small intestine
(the jejunum) [17, 18], the right hemicolon with the
terminal ileum, the colon transversum or the left hemi-
colon as the interposition [16, 18, 19]. Experience has
also been reported with dystopia of the right hemicolon
[18]. 
If a long replacement tube is necessary to recreate
oesophageal passage continuity, Furst et al [19] suggest
the use of the left hemicolon including the oral part of the
colon ascendens, with preservation of the arteria colica
sinistra, the riolan-anastomosis and the arteria colica
media. The blood supply of the left hemicolon via a few
major supply branches and not via multiple small arcades,
which often is the case in the area of the right hemicolon,
is an advantage of the left hemicolon for interposition
when compared to the right hemicolon. This permits
a greater variability in length of the oesophageal
replacement [21]. 
If a diverticulosis exists, which appears more often
in the area of the colon descendens than inside of the
colon ascendens, the left hemicolon cannot be used to
recreate passage continuity. The creation of an iso-
peristaltic or anisoperistaltic colon interposition does not
have clinical relevance for the transportation of the chyme
through the oesophageal replacement, since this process
is essentially influenced by gravity rather than by
peristaltic movements [21]. The small intestine can be
seen as an alternative organ, if the colon cannot be used
because of previous surgery or colonic disease [17].
However, which method is applied, can only be decided
intraoperatively. 
We recommend the following considerations as
important when involving the use of the right hemicolon,
as was the case with our 69 year-old male patient. (1)
After preoperative angiographic display of the mesen-
terial vessels, an adequate long arteria colica media for
blood supply of the interposition should be verified and
confirmed as haemodynamically sufficient in the intra-
operative site via branching off of the blood vessels. (2) It
is the nature of both oesophagus and terminal ileum that
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they have the same kind of lumina. This is beneficial for
the suture of the anastomosis. (3) If the right hemicolon is
used as an interposition, an ileotransversostomy is
necessary in order to recreate the passage continuity of
the intestine. A small intestine-large intestine anastomosis
allows more favourable healing than a colon anastomosis,
which is necessary when favouring the left hemicolon as
an oesophageal replacement. (4) The terminal ileum and
the colon ascendens are less populated with germs and
have a consecutively reduced foetor ex ore. (5) For the
sake of completeness it must be mentioned that with this
type of reconstruction the obligatory appendectomy with
a consequent additional risk of insufficiency has been
proved to be unfavorable.
Following our evaluation from the literature of an
inevitably small number of cases we consider that an
acceptable morbidity rate (general complications 37.1%,
anastomosis insufficiency 14.8%, ischemic colitis 3.0%)
and an acceptable operative mortality rate (5.9%) can
be currently obtained using the strategies we have
described [18].
Post-operative irradiation and chemotherapy are
controversial because leiomyosarcoma is classified as
relatively radiation resistant [3, 14], although tumour
reduction after radiotherapy of a non-resectable leiomyo-
sarcoma has been described [14]. There is also a relatively
low response rate to chemotherapy of 10–30% when
compared to other soft tissue sarcomas [14].
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